Chapter 5_Signaling Between Neurons Flashcards

1
Q

Electrical synapses

A

Synapses where electrical signals pass directly from one neuron to another through gap junctions, allowing for rapid signal transmission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chemical synapses

A

Synapses where neurotransmitters are released from one neuron and bind to receptors on another neuron, allowing for slower, but more modifiable, signal transmission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Connexons

A

Protein channels that form gap junctions in electrical synapses, allowing ions and small molecules to pass directly between cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Synaptic vesicles

A

Membrane-bound sacs in the presynaptic neuron that store neurotransmitters and release them into the synaptic cleft upon receiving an action potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neurotransmitters

A

Chemical substances released by neurons at synapses that transmit signals to other neurons, muscle cells, or gland cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Synaptic cleft

A

The small gap between the presynaptic and postsynaptic neurons at a chemical synapse, across which neurotransmitters diffuse to transmit a signal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ionotropic receptors

A

Receptors that directly control an ion channel when a neurotransmitter binds to them, resulting in rapid changes in the postsynaptic cell’s membrane potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metabotropic receptors

A

Receptors that indirectly influence ion channels through the activation of second messengers when a neurotransmitter binds to them, leading to slower but more prolonged effects on the postsynaptic cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exocytosis

A

The process by which synaptic vesicles fuse with the presynaptic membrane to release neurotransmitters into the synaptic cleft.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endocytosis

A

The process by which a cell takes in materials from the outside by engulfing and fusing them with its plasma membrane, often used by neurons to retrieve synaptic vesicle membrane after neurotransmitter release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Synaptic plasticity

A

The ability of synapses to strengthen or weaken over time, in response to increases or decreases in their activity, which is crucial for learning and memory.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Retrograde signaling

A

Communication that travels from the postsynaptic neuron back to the presynaptic neuron, often involving signaling molecules like endocannabinoids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Endocannabinoids

A

Lipid-based neurotransmitters that bind to cannabinoid receptors and can modulate neurotransmitter release, involved in retrograde signaling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GABA (gamma-aminobutyric acid)

A

The primary inhibitory neurotransmitter in the central nervous system, which reduces neuronal excitability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Glutamate

A

The primary excitatory neurotransmitter in the central nervous system, involved in most aspects of normal brain function including cognition, memory, and learning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acetylcholine

A

A neurotransmitter involved in muscle activation, attention, and arousal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Dopamine

A

A neurotransmitter involved in reward, motivation, and motor control, with dysfunctions linked to conditions like Parkinson’s disease and schizophrenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Serotonin

A

A neurotransmitter that affects mood, appetite, and sleep, with dysregulation associated with depression and anxiety disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Norepinephrine

A

A neurotransmitter involved in arousal and alertness, also known as noradrenaline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Neuropeptides

A

Large protein-like molecules used by neurons to communicate with each other, influencing the activity of the brain and body in specific ways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Nitric oxide (NO)

A

A gaseous neurotransmitter involved in various neural processes, including vasodilation and synaptic plasticity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Botulinum toxin

A

A neurotoxin produced by the bacterium Clostridium botulinum, which inhibits acetylcholine release and causes paralysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Synaptotagmin

A

A calcium-binding protein that plays a key role in triggering neurotransmitter release at synapses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

SNARE proteins

A

A family of proteins that mediate the fusion of synaptic vesicles with the presynaptic membrane to release neurotransmitters.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Reuptake

A

The process by which neurotransmitters are taken back into the presynaptic neuron after they have been released into the synaptic cleft, terminating the signal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Selective serotonin reuptake inhibitors (SSRIs)

A

A class of drugs used to treat depression and anxiety by inhibiting the reuptake of serotonin, increasing its levels in the synaptic cleft.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Gap junction

A

Specialized intercellular connections that allow direct electrical communication between adjacent cells, facilitating rapid signal transmission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Charcot-Marie-Tooth (CMT) disease

A

A hereditary disorder that affects the peripheral nerves, leading to muscle weakness and atrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Presynaptic neuron

A

The neuron that releases neurotransmitters into the synapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Postsynaptic neuron

A

The neuron that receives neurotransmitters from the presynaptic neuron.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Receptor

A

A protein molecule that receives and responds to a neurotransmitter or hormone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Neuromuscular junction

A

The synapse between a motor neuron and a muscle fiber, where acetylcholine is released to trigger muscle contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Small vesicles

A

Synaptic vesicles that contain classical neurotransmitters and are released in response to low-frequency stimulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Large dense-core vesicles

A

Vesicles that contain neuropeptides and are released in response to high-frequency stimulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Electron microscopy

A

A technique that uses a beam of electrons to create an image of a specimen, allowing for very high resolution and magnification.

36
Q

Vesicular GABA transporters (VGAT)

A

Transport proteins that load GABA into synaptic vesicles.

37
Q

Vesicular glutamate transporters (VGluT)

A

Transport proteins that load glutamate into synaptic vesicles.

38
Q

Vesicular acetylcholine transporter (VAChT)

A

Transport proteins that load acetylcholine into synaptic vesicles.

39
Q

Vesicular monoamine transporters (VMATs)

A

Transport proteins that load monoamines (dopamine, norepinephrine, serotonin) into synaptic vesicles.

40
Q

Vesicular ATP-ase

A

An enzyme that provides the energy for loading neurotransmitters into synaptic vesicles.

41
Q

Antiporters

A

Transport proteins that move two different molecules or ions across a membrane in opposite directions.

42
Q

Readily releasable pool (RRP) vesicles

A

Synaptic vesicles that are docked at the presynaptic membrane and ready to release neurotransmitters upon stimulation.

43
Q

Recycling pool vesicles

A

Synaptic vesicles that are available for release but are not docked at the presynaptic membrane.

44
Q

Reserve pool vesicles

A

Synaptic vesicles that are stored away from the presynaptic membrane and are only used during high-frequency stimulation.

45
Q

V-SNAREs

A

SNARE proteins located on synaptic vesicles that are involved in vesicle docking and fusion.

46
Q

T-SNAREs

A

SNARE proteins located on the presynaptic membrane that are involved in vesicle docking and fusion.

47
Q

Botulism

A

A rare but serious illness caused by a toxin that attacks the body’s nerves, leading to muscle paralysis.

48
Q

Voltage-gated calcium channels

A

Ion channels that open in response to depolarization and allow calcium ions to enter the cell, triggering neurotransmitter release.

49
Q

Full fusion

A

A mechanism of neurotransmitter release where the vesicle membrane completely merges with the presynaptic membrane.

50
Q

Kiss-and-run

A

A mechanism of neurotransmitter release where the vesicle briefly contacts the presynaptic membrane and releases its contents before detaching.

51
Q

SNARE complex

A

A complex of SNARE proteins that mediates the fusion of synaptic vesicles with the presynaptic membrane.

52
Q

Active site

A

The region of a receptor or enzyme where the binding of a neurotransmitter or substrate occurs.

53
Q

Orthosteric site

A

The primary site on a receptor where a neurotransmitter or drug binds to exert its effect.

54
Q

Ligands

A

Molecules that bind to specific receptors to exert their biological effects.

55
Q

Ligand-gated ion channels

A

Ion channels that open in response to the binding of specific molecules (ligands) such as neurotransmitters.

56
Q

G proteins

A

Guanine nucleotide-binding proteins that transmit signals from receptors to target enzymes or ion channels inside the cell.

57
Q

G protein-coupled receptors (GPCRs)

A

A large family of receptors that interact with G proteins to transmit signals inside the cell.

58
Q

Presynaptic receptors

A

Receptors located on the presynaptic neuron that modulate neurotransmitter release.

59
Q

Autoreceptors

A

Presynaptic receptors that respond to the neurotransmitter released by the same neuron, providing feedback regulation.

60
Q

Excitotoxicity

A

A pathological process where neurons are damaged and killed by excessive stimulation by neurotransmitters such as glutamate.

61
Q

Glycine

A

An inhibitory neurotransmitter in the central nervous system, particularly in the spinal cord.

62
Q

Dopamine (DA)

A

A neurotransmitter involved in reward, motivation, and motor control.

63
Q

Ventral tegmental area (VTA)

A

A part of the brain involved in the reward system and the release of dopamine.

64
Q

Substantia nigra

A

A part of the brain that plays an important role in reward and movement, contains dopaminergic neurons.

65
Q

D1 and D5 receptors

A

Subtypes of dopamine receptors that are typically excitatory.

66
Q

D2, D3, and D4 receptors

A

Subtypes of dopamine receptors that are typically inhibitory.

67
Q

Serotonin (5-HT)

A

A neurotransmitter that affects mood, appetite, and sleep.

68
Q

Raphe nucleus

A

A cluster of nuclei in the brainstem involved in the release of serotonin.

69
Q

5-HT2A receptor

A

A subtype of serotonin receptor involved in various neural processes, including mood regulation.

70
Q

5-HT5 receptor

A

A subtype of serotonin receptor with various functions in the central nervous system.

71
Q

5-HT3 receptor

A

A subtype of serotonin receptor that is a ligand-gated ion channel.

72
Q

Fluoxetine

A

A selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety.

73
Q

Parkinson’s disease (PD)

A

A neurodegenerative disorder characterized by the death of dopaminergic neurons in the substantia nigra, leading to motor control issues.

74
Q

L-DOPA-induced dyskinesia (LID)

A

Involuntary movements that can result from long-term use of L-DOPA in the treatment of Parkinson’s disease.

75
Q

Hyperkinesias

A

Abnormally increased muscle movements.

76
Q

Deep brain stimulation

A

A surgical treatment for Parkinson’s disease and other conditions that involves implanting electrodes in the brain to modulate neural activity.

77
Q

Acetylcholine (ACh)

A

A neurotransmitter involved in muscle activation, attention, and arousal.

78
Q

Nicotinic acetylcholine receptors (nAChRs)

A

Ionotropic receptors for acetylcholine found in the central and peripheral nervous systems.

79
Q

Norepinephrine (NE)

A

A neurotransmitter involved in arousal and alertness, also known as noradrenaline.

80
Q

Beta blockers

A

Medications that block beta-adrenergic receptors, used to treat high blood pressure and other conditions.

81
Q

Atypical neurotransmitters

A

Neurotransmitters that do not fit the classic definition, such as endocannabinoids and nitric oxide.

82
Q

Enkephalin

A

A type of neuropeptide involved in regulating pain and reward.

83
Q

Opioid receptors

A

Receptors that bind to opioid peptides and opiate drugs, involved in pain relief and reward.

84
Q

Endocannabinoids (eCBs)

A

Lipid-based neurotransmitters that bind to cannabinoid receptors and can modulate neurotransmitter release.

85
Q

CB1 receptors

A

Cannabinoid receptors primarily found in the brain and central nervous system.

86
Q

CB2 receptors

A

Cannabinoid receptors primarily found in the peripheral nervous system and immune cells.